Sana Biotechnology press release ( SANA ): Q1 GAAP EPS of -$0.17 in-line. Q1 2026 cash position of $101.1 million and pro forma cash position of $128.9 million, including approximately $25.0 million equity investment from Mayo Clinic collaboration and recent at the market offering facility (ATM) activity; expected cash runway into 2027 More on Sana Biotechnology Sana Biotechnology: Mayo Clinic Dea...
Sana Biotechnology press release ( SANA ): Q1 GAAP EPS of -$0.17 in-line. Q1 2026 cash position of $101.1 million and pro forma cash position of $128.9 million, including approximately $25.0 million equity investment from Mayo Clinic collaboration and recent at the market offering facility (ATM) activity; expected cash runway into 2027 More on Sana Biotechnology Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript Sana Biotech rises as Mayo Clinic partners for diabetes therapy Sana Biotechnology GAAP EPS of -$0.21 misses by $0.07
naphtalina/iStock via Getty Images Investors may be overlooking a significant macro transition as equity ( SPY ) ( DIA ) ( QQQ ) markets continue their steady climb on semiconductor ( SOX ) strength, according to a new warning from Seeking Alpha analyst Damir Tokic on Monday. Tokic cautioned that markets are “gradually pricing a regime change to inflation” beneath the surface calm. He pointed to s...
naphtalina/iStock via Getty Images Investors may be overlooking a significant macro transition as equity ( SPY ) ( DIA ) ( QQQ ) markets continue their steady climb on semiconductor ( SOX ) strength, according to a new warning from Seeking Alpha analyst Damir Tokic on Monday. Tokic cautioned that markets are “gradually pricing a regime change to inflation” beneath the surface calm. He pointed to several converging signals: odds of a Federal Reserve rate hike nearing 45% for April 2027, the 10-year Treasury yield ( US10Y ) trading above 4.40%, breakeven inflation at 2.49%, and crude oil ( USO ) ( BNO ) prices increasingly reflecting the ongoing Middle East stalemate. The central concern is that markets are pricing these shifts slowly enough to keep risk appetite intact. With the VIX ( VIX ) still below 20, investors have continued piling into semiconductor exposure through vehicles like the VanEck Semiconductor ETF ( SMH ). Tokic described the current setup as “very unstable” and “fragile,” warning that the same calm supporting equities could leave markets vulnerable to a sudden volatility spike and sharp correction. Wall Street’s major market averages closed modestly higher on Monday, with the S&P 500 ( SP500 ) closing above 7.4K for the first time, even as there seemed to be no end in sight to the U.S.-Iran conflict as resolution talks fizzled. More on the Markets Record U.S. Stocks: Disconnect Or Not? SPY: In Chips, We Trust Dow Jones, Nasdaq And S&P 500 Intraday Levels - Tech Does Not Wait On CPI And Geopolitics Wall Street ends slightly higher as U.S.-Iran resolution talks fizzle Market bubble could have more room to run - Dan Niles
Harmonic press release ( HLIT ): Q1 Non-GAAP EPS of $0.21 beats by $0.09 . Revenue of $171.8M (+29.1% Y/Y) beats by $69.69M . Backlog and deferred revenue of $582.1 million, an increase of 87%, compared to $311.7 million last year Cash: $109.0 million at April 3, 2026, compared to $124.1 million at December 31, 2025 Repurchased approximately 4.2 million shares of common stock for $43.0 million in ...
Harmonic press release ( HLIT ): Q1 Non-GAAP EPS of $0.21 beats by $0.09 . Revenue of $171.8M (+29.1% Y/Y) beats by $69.69M . Backlog and deferred revenue of $582.1 million, an increase of 87%, compared to $311.7 million last year Cash: $109.0 million at April 3, 2026, compared to $124.1 million at December 31, 2025 Repurchased approximately 4.2 million shares of common stock for $43.0 million in Q1 Continuing Operations Business Highlights - Broadband Commercially deployed our cOS™ solution with 150 customers, serving 45.7 million cable modems, with ongoing expansion across all tier-1 accounts and new customer wins Rest-of-Market bookings exceeded 50% of total Q1 bookings, reflecting meaningful progress in customer diversification Secured additional DOCSIS 4.0 customer wins and deployments, with a growing pipeline Achieved multiple fiber wins, including several international providers, with fiber products representing over 14% of Appliance and Integration revenue during the past year More on Harmonic Harmonic Inc. 2025 Q4 - Results - Earnings Call Presentation Harmonic Inc. (HLIT) Q4 2025 Earnings Call Transcript Harmonic outlines $440M–$480M 2026 broadband revenue target as pure-play transformation accelerates Harmonic Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Harmonic
OMAHA, Neb. , May 11, 2026 (GLOBE NEWSWIRE) -- Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months ended March 31, 2026.
OMAHA, Neb. , May 11, 2026 (GLOBE NEWSWIRE) -- Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months ended March 31, 2026.
Plenty of tech companies went public over the past year, but some of those tech IPOs have already fizzled out amid intensifying macro headwinds. Two of the better IPOs that resisted that sell-off were Circle (NYSE: CRCL) and CoreWeave (NASDAQ: CRWV) . Circle's stock has more than quadrupled from its IPO price of $31, while CoreWeave's stock has nearly tripled from its IPO price of $40. Let's see w...
Plenty of tech companies went public over the past year, but some of those tech IPOs have already fizzled out amid intensifying macro headwinds. Two of the better IPOs that resisted that sell-off were Circle (NYSE: CRCL) and CoreWeave (NASDAQ: CRWV) . Circle's stock has more than quadrupled from its IPO price of $31, while CoreWeave's stock has nearly tripled from its IPO price of $40. Let's see why these two tech IPOs impressed the market, and why they're still worth buying in this frothy market this month. Image source: Getty Images. Continue reading
Buckle Up For A Wild Week Authored by James Howard Kunstler, The Earth Moves Just a Bit “Operation Epic Fury was the loud one. Operation Economic Fury is the quiet one. . . . While the carriers were on television, Treasury was doing the actual demolition.” - Jesús Enrique Rosas on X Expect a consequential week. The Persian Gulf remains closed and colossal oil slicks leak out of Kharg Island while ...
Buckle Up For A Wild Week Authored by James Howard Kunstler, The Earth Moves Just a Bit “Operation Epic Fury was the loud one. Operation Economic Fury is the quiet one. . . . While the carriers were on television, Treasury was doing the actual demolition.” - Jesús Enrique Rosas on X Expect a consequential week. The Persian Gulf remains closed and colossal oil slicks leak out of Kharg Island while Iran blusters and stomps its feet. No one can even try to buy its oil anymore, not even China. The sanctions are too onerous. Iran’s wells must be shut in now. Imagine how the production chiefs out in the oil fields are howling at their insane IRGC overseers. Iran has no economy left operating. Iran’s domestic security force, the Basij (Sâzmân-e Basij-e Mostaz’afin, or “Mobilization of the Oppressed”) is strangling anyone who expresses discontent in the streets, not a good look for a regime that can’t survive without the pretense of popular support. Late Sunday, the US President rejected the Tehran’s latest conditions for peace out of hand. They are trying to jerk the whole world around, even while they whirl around the drain. Despite what you read in The New York Times — Iran’s US-based chief cheerleader — it is probably a matter of days now before capitulation. The ball is in America’s court this morning, a real hanging lob shot. The return is apt to be hard. Of course, whatever official utterances come out of Iran, you must discount by about 99.9-percent. For now, there is nothing but the morning fog of suspense. But strange doings are a’foot elsewhere. You might have noticed that the UK’s labor government got drubbed in local elections, losing nearly 1,500 council seats, a humiliating repudiation. It’s a matter of days before PM Keir Starmer will have to hang it up. His possible replacements are utterly unknown to Americans — Angela Rayner, a former Deputy PM, Energy Secretary Ed Milliband, Health Sec’y Wes Streeting — and any of them is just a place-holder for the elec...
Allied Gaming & Entertainment ( Nasdaq: AGAE ) on Monday said it received a Nasdaq staff determination notice related to its failure to regain compliance with the exchange’s minimum $1.00 bid price requirement. The company said it plans to request a hearing before an independent Nasdaq Hearings Panel by May 13 and intends to seek an extended stay of any suspension pending the hearing process. Alli...
Allied Gaming & Entertainment ( Nasdaq: AGAE ) on Monday said it received a Nasdaq staff determination notice related to its failure to regain compliance with the exchange’s minimum $1.00 bid price requirement. The company said it plans to request a hearing before an independent Nasdaq Hearings Panel by May 13 and intends to seek an extended stay of any suspension pending the hearing process. Allied Gaming said it is considering measures including a reverse stock split and other actions aimed at raising its share price above $1.00 to maintain its Nasdaq listing. Nasdaq also noted that the company has not yet filed its annual report on Form 10-K for the year ended December 31, 2025, the company said. The company said its shares will continue trading on Nasdaq under the ticker “AGAE” during the initial 15-day stay period following the hearing request. Source: Press Release More on Allied Esports Entertainment Allied Gaming receives Nasdaq notice over delayed annual report Historical earnings data for Allied Esports Entertainment Financial information for Allied Esports Entertainment
Nvidia stock logged its third record close of the year Monday as investor enthusiasm over the chip sector spilled over to the relative laggard of the bunch. Nvidia has risen 13% and added roughly $550 billion in market capitalization over that four-day streak. For reference, only 18 U.S. companies, including Nvidia itself, have a market cap greater than $550 billion.
Nvidia stock logged its third record close of the year Monday as investor enthusiasm over the chip sector spilled over to the relative laggard of the bunch. Nvidia has risen 13% and added roughly $550 billion in market capitalization over that four-day streak. For reference, only 18 U.S. companies, including Nvidia itself, have a market cap greater than $550 billion.
Power Solutions press release ( PSIX ): Q1 Non-GAAP EPS of $0.36 misses by $0.16 . Revenue of $128.59M (-5.1% Y/Y) misses by $32.21M . Outlook for 2026 Given ongoing variability in order timing and market conditions, the Company is not providing formal full-year guidance at this time. Based on current visibility, the Company currently expects second-quarter 2026 revenue to be generally consistent ...
Power Solutions press release ( PSIX ): Q1 Non-GAAP EPS of $0.36 misses by $0.16 . Revenue of $128.59M (-5.1% Y/Y) misses by $32.21M . Outlook for 2026 Given ongoing variability in order timing and market conditions, the Company is not providing formal full-year guidance at this time. Based on current visibility, the Company currently expects second-quarter 2026 revenue to be generally consistent with the first quarter on a sequential basis. The Company anticipates stronger sales growth in the second half of 2026, approximately in line with sales in the second half of 2025, as larger Power Systems orders move into production and are recognized as revenue. However, the timing and ultimate volume of those shipments remain subject to customer scheduling, manufacturing throughput, supply chain factors and other variables. There can be no assurance that those orders will translate to a uniformly stronger second half. Continued softness in the oil and gas end market is expected to weigh on quarterly revenue trends, and capacity ramp-up activities at the Company’s Wisconsin operations and their related cost effects on gross margin are expected to continue. Shares -38% AH. More on Power Solutions Power Solutions: From Cautious Buy To Disciplined Profit Booking And A Patient Wait Power Solutions: Market Overreacting To Temporary Margin Pressure, Reiterating Strong Buy Power Solutions: Private Earnings Call Revelations Make Me Even More Bullish SA analyst upgrades/downgrades: PLTR, INTC, BROS, PSIX Power Solutions International acquires MTL Manufacturing & Equipment
CleanSpark press release ( CLSK ): Q2 GAAP EPS of -$1.52 misses by $0.80 . Revenue of $136.4M (-24.9% Y/Y) misses by $3.5M . Doubled MW under contract year-over-year including 585 MW of ERCOT-approved capacity Increased Bitcoin holdings by 14% and average monthly hashrate by 18% year-over-year Shares -3% . More on CleanSpark CleanSpark Is Positioned For A Re-Rating As AI Demand Builds CleanSpark: ...
CleanSpark press release ( CLSK ): Q2 GAAP EPS of -$1.52 misses by $0.80 . Revenue of $136.4M (-24.9% Y/Y) misses by $3.5M . Doubled MW under contract year-over-year including 585 MW of ERCOT-approved capacity Increased Bitcoin holdings by 14% and average monthly hashrate by 18% year-over-year Shares -3% . More on CleanSpark CleanSpark Is Positioned For A Re-Rating As AI Demand Builds CleanSpark: 1.8 GW Of Power And An Asymmetric Buying Opportunity Twenty One Capital sees lowest short interest in April among mid-mega cap firms CleanSpark Q2 2026 Earnings Preview Seeking Alpha’s Quant Rating on CleanSpark
Piper Sandler analyst Alexander Potter wrote that Tesla (TSLA) investors entering at the current stock price are practically buying into the upside of the company's Optimus robotics "for free." Yahoo Finance Senior Autos Reporter Pras Subramanian breaks down this analyst note examining the future value of the EV maker's robotics business.
Piper Sandler analyst Alexander Potter wrote that Tesla (TSLA) investors entering at the current stock price are practically buying into the upside of the company's Optimus robotics "for free." Yahoo Finance Senior Autos Reporter Pras Subramanian breaks down this analyst note examining the future value of the EV maker's robotics business.
In trading on Monday, shares of the GraniteShares 2x Long ISRG Daily ETF (Symbol: ISUL) entered into oversold territory, changing hands as low as $19.25 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator us
In trading on Monday, shares of the GraniteShares 2x Long ISRG Daily ETF (Symbol: ISUL) entered into oversold territory, changing hands as low as $19.25 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator us
Bristol-Myers Squibb ( BMY ) shares fell for seven straight sessions, as the stock was down 0.9% at $55.64 on Monday. The New Jersey-based pharma giant fell 3.5% in the preceding six sessions. The stock is down 5% over the past one month, while it has advanced 4% so far this year. Most recently, Bristol-Myers Squibb reported better-than-expected Q1 2026 financials as its growth portfolio continued...
Bristol-Myers Squibb ( BMY ) shares fell for seven straight sessions, as the stock was down 0.9% at $55.64 on Monday. The New Jersey-based pharma giant fell 3.5% in the preceding six sessions. The stock is down 5% over the past one month, while it has advanced 4% so far this year. Most recently, Bristol-Myers Squibb reported better-than-expected Q1 2026 financials as its growth portfolio continued to offset a slump in demand for its legacy products. "Bristol Myers Squibb faces a major patent cliff but is well-equipped with a robust pipeline and significant CAR-T optionality," pointed out a recent Seeking Alpha analysis. Looking at Seeking Alpha's Quant Rating, BMY has a Hold rating with a score of 3.4 out of 5. The company received an A+ in the prospect of profitability, while it got a D in growth factor. Turning to the Wall Street community , 10 analysts gave BMY a Buy and above rating. 18 analysts have given the stock a Hold recommendation, while one recommended Sell. Seeking Alpha analysts are positive and see the stock as a Buy. More on Bristol-Myers Squibb Company Bristol-Myers Squibb: The CAR-T Giant The Market Is Undervaluing Bristol-Myers Squibb Company 2026 Q1 - Results - Earnings Call Presentation Bristol-Myers Squibb Company (BMY) Q1 2026 Earnings Call Transcript FDA asks for feedback on repurposing drugs for new indications FDA food head eyed as acting commissioner - report
In trading on Monday, shares of the Defiance Daily Target 2X Short IONQ ETF (Symbol: IONZ) entered into oversold territory, changing hands as low as $3.165 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator
In trading on Monday, shares of the Defiance Daily Target 2X Short IONQ ETF (Symbol: IONZ) entered into oversold territory, changing hands as low as $3.165 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator
Coherus BioSciences press release ( CHRS ): Q1 Non-GAAP EPS of -$0.25 beats by $0.02 . Revenue of $12.31M (+62.0% Y/Y) misses by $2.03M . LOQTORZI revenue for Q1 2026 was $11.8 million, a 61% increase over $7.3 million in Q1 2025, and a 5% decrease versus the $12.4 million in Q4 2025, driven by the impact of severe weather events in Q1 as well as normal seasonality. More on Coherus BioSciences Coh...
Coherus BioSciences press release ( CHRS ): Q1 Non-GAAP EPS of -$0.25 beats by $0.02 . Revenue of $12.31M (+62.0% Y/Y) misses by $2.03M . LOQTORZI revenue for Q1 2026 was $11.8 million, a 61% increase over $7.3 million in Q1 2025, and a 5% decrease versus the $12.4 million in Q4 2025, driven by the impact of severe weather events in Q1 as well as normal seasonality. More on Coherus BioSciences Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript Coherus: Downgrade To 'Hold' On Potential Advancement Of Anti-CCR8 CHS-114 Coherus outlines $175M annualized LOQTORZI target by 2028 as commercial expansion accelerates Coherus BioSciences Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Coherus BioSciences
Harrow Health press release ( HROW ): Q1 GAAP EPS of -$0.74 misses by $0.34 . Revenue of $44.2M (-7.6% Y/Y) misses by $8.29M . Full-year 2026 revenue guidance reaffirmed at $350 million to $365 million vs consensus of $351.30M. Shares -9.3% AH. More on Harrow Health Harrow: Now Is The Buy Time Harrow: Probably A Short-Term Market Overreaction Harrow Emerging As Dominant Operator In U.S. Ophthalmic...
Harrow Health press release ( HROW ): Q1 GAAP EPS of -$0.74 misses by $0.34 . Revenue of $44.2M (-7.6% Y/Y) misses by $8.29M . Full-year 2026 revenue guidance reaffirmed at $350 million to $365 million vs consensus of $351.30M. Shares -9.3% AH. More on Harrow Health Harrow: Now Is The Buy Time Harrow: Probably A Short-Term Market Overreaction Harrow Emerging As Dominant Operator In U.S. Ophthalmic Market Harrow prices $50M senior unsecured notes due 2030 at 8.625% Harrow announces $50M add-on senior notes offering
Applied Materials and TSMC have agreed a new collaboration focused on accelerating AI and high performance computing chip technologies. The partnership will concentrate on next generation materials engineering, equipment development, and advanced process integration. Applied’s EPIC Center will act as a hub for joint work on future AI semiconductor manufacturing capabilities. For investors tracking...
Applied Materials and TSMC have agreed a new collaboration focused on accelerating AI and high performance computing chip technologies. The partnership will concentrate on next generation materials engineering, equipment development, and advanced process integration. Applied’s EPIC Center will act as a hub for joint work on future AI semiconductor manufacturing capabilities. For investors tracking NasdaqGS:AMAT, this move adds fresh context to a stock that recently closed at $435.44. The...
Transit advocates laud first stations to open in city in more than 25 years, with World Cup and Olympics coming to town The roughly 12-mile (19km) drive along Wilshire Boulevard from Los Angeles’s downtown core to its Westside region can be a soul-crushing experience. The road is among the busiest in Los Angeles, winding through Westlake, Koreatown, the famed Miracle Mile, Beverly Hills, Century C...
Transit advocates laud first stations to open in city in more than 25 years, with World Cup and Olympics coming to town The roughly 12-mile (19km) drive along Wilshire Boulevard from Los Angeles’s downtown core to its Westside region can be a soul-crushing experience. The road is among the busiest in Los Angeles, winding through Westlake, Koreatown, the famed Miracle Mile, Beverly Hills, Century City, Westwood and Santa Monica before ending at the bluffs overlooking the Pacific coast highway, a journey that can take an hour or even two at rush hour. For decades, Angelenos accepted this time-eating crawl as fate. But this week, traversing this bustling corridor reached another level – about 50-70ft underground to be precise. How about Union Station to Beverly Hills in 21 minutes? Continue reading...
(RTTNews) - After turning in a strong performance last week, stocks showed a lack of direction over the course of the trading session on Monday. The major averages spent the day bouncing back and forth across the unchanged line before eventually closing modestly higher.
(RTTNews) - After turning in a strong performance last week, stocks showed a lack of direction over the course of the trading session on Monday. The major averages spent the day bouncing back and forth across the unchanged line before eventually closing modestly higher.
Catalyst Pharmaceuticals, Inc. press release ( CPRX ): Q1 Non-GAAP EPS of $0.79 beats by $0.15 . Revenue of $149.3M (+5.9% Y/Y) beats by $1.12M . FIRDAPSE Q1 2026 product revenue, net was $98.9 million, an 18.1% year-over-year increase, primarily driven by increases in sales volumes. AGAMREE Q1 2026 product revenue, net was $36.7 million, compared to product revenue, net of $22.0 million in Q1 202...
Catalyst Pharmaceuticals, Inc. press release ( CPRX ): Q1 Non-GAAP EPS of $0.79 beats by $0.15 . Revenue of $149.3M (+5.9% Y/Y) beats by $1.12M . FIRDAPSE Q1 2026 product revenue, net was $98.9 million, an 18.1% year-over-year increase, primarily driven by increases in sales volumes. AGAMREE Q1 2026 product revenue, net was $36.7 million, compared to product revenue, net of $22.0 million in Q1 2025. The results underscore continued sales volume growth and increasing prescriber engagement. FYCOMPA® Q1 2026 product revenue, net was $13.8 million, a 61.3% year-over-year decrease following loss of exclusivity in 2025. More on Catalyst Pharmaceuticals, Inc. Catalyst Pharmaceuticals: Favorable Trial Outcome Could Be A Meaningful Overhang Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2025 Earnings Call Transcript Catalyst Pharmaceuticals, Inc. Q1 2026 Earnings Preview Key deals this week: Roche, Bayer, eBay, Bullish, and more
Simon Property Group ( SPG ) on Monday declared a quarterly common stock dividend of $2.25 for the second quarter of 2026. This is an increase of $0.15, or 7.1% year-over-year. The dividend will be payable on June 30, 2026 to shareholders of record on June 9, 2026. Simon's Board declared the quarterly dividend on its 8 3/8% Series J Cumulative Redeemable Preferred Stock (SPGPrJ) of $1.046875 per s...
Simon Property Group ( SPG ) on Monday declared a quarterly common stock dividend of $2.25 for the second quarter of 2026. This is an increase of $0.15, or 7.1% year-over-year. The dividend will be payable on June 30, 2026 to shareholders of record on June 9, 2026. Simon's Board declared the quarterly dividend on its 8 3/8% Series J Cumulative Redeemable Preferred Stock (SPGPrJ) of $1.046875 per share, payable on June 30, 2026 to shareholders of record on June 16, 2026. More on Simon Property Simon Property Group: Leadership Change Doesn't Break The Story Simon Property Group: Implications On The Passing Of The CEO Simon Property Group, Inc. (SPG) Presents at Citi's Miami Global Property CEO Conference 2026 Transcript Simon Property FFO of $3.17 beats by $0.14, revenue of $1.76B beats by $250M SPG Q1 preview: Occupancy, leasing trends, and leadership shift in focus